Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
  1. 4 Grant or award Chief Technology Officer acquired 344 shares (grant or award)
  2. 4 Open-market sale Director sold 7,142 shares at $28.99 ($207,023)
  3. 4 Insider Changes in Ownership
  4. 4 Returned to the company Director returned 15,889 shares (to the company)
  5. 4 Open-market sale Chief Scientific Officer sold 19,360 shares at $31.97 ($618,949)
  6. 4 Open-market sale Chief Scientific Officer sold 40,000 shares at $31.47 ($1,258,800)
  7. 4 Open-market sale Lambert Nicole sold 6,649 shares at an average $27.01 ($179,586)
  8. 4 Insider Changes in Ownership
  9. 4 Grant or award Chief Growth Officer acquired 16,420 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale Chief People Officer sold 58,000 shares at $30.00 ($1,740,000)
  12. 4 Grant or award President and CEO acquired 159,915 shares (grant or award)
  13. 4 Grant or award Chief People Officer acquired 13,326 shares (grant or award)
  14. 4 Grant or award E.V.P., General Counsel acquired 18,879 shares (grant or award)
  15. 4 Grant or award EVP Strategy and Innovation acquired 10,661 shares (grant or award)
  16. 4 Grant or award Chief Technology Officer acquired 13,326 shares (grant or award)
  17. 4 Grant or award Chief Scientific Officer acquired 19,347 shares (grant or award)
  18. 4 Grant or award President, Myriad Neuroscience acquired 15,441 shares (grant or award)
  19. 4 Grant or award President, Myriad Oncology, acquired 29,556 shares (grant or award)
  20. 4 Grant or award Chief Financial Officer acquired 32,774 shares (grant or award)

Page 19 of 65 · 1,294 filings